Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study

Kitko CL, et al.

Citation

J Clin Oncol. 2023 Apr 1;41(10):1864-1875.

PMID

36459673